Sec Form 3 Filing - Becklund Irene @ Hims & Hers Health, Inc. - 2021-11-15

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Becklund Irene 2. Issuer Name and Ticker or Trading Symbol Hims & Hers Health, Inc. [ HIMS] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Interim PFO/PAO (Last) (First) (Middle) 2269 CHESTNUT STREET, #523 3. Date of Earliest Transaction (MM/DD/YY) 11/15/2021 (Street) SAN FRANCISCO, CA94123 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class A Common Stock 16,183 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (right to buy) $ 1.75 ( 1 ) 07/09/2029 Class A Common Stock 27,178 D Stock Option (right to buy) $ 9.41 ( 2 ) 12/23/2030 Class A Common Stock 22,648 D Restricted Stock Unit $ 0 ( 3 ) ( 3 ) Class A Common Stock 67,947 D Restricted Stock Unit $ 0 ( 4 ) ( 4 ) Class A Common Stock 2,564 D Restricted Stock Unit $ 0 ( 5 ) ( 5 ) Class A Common Stock 2,215 D Restricted Stock Unit $ 0 ( 5 ) ( 5 ) Class A Common Stock 6,646 D Restricted Stock Unit $ 0 ( 4 ) ( 4 ) Class A Common Stock 51 D Restricted Stock Unit $ 0 ( 5 ) ( 5 ) Class A Common Stock 44 D Restricted Stock Unit $ 0 ( 5 ) ( 5 ) Class A Common Stock 132 D Restricted Stock Unit $ 0 ( 5 ) ( 5 ) Class A Common Stock 43,002 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Becklund Irene 2269 CHESTNUT STREET, #523 SAN FRANCISCO, CA94123 Interim PFO/PAO Signatures /s/ Alexandra Cotter Wilkins, Attorney-in-Fact 11/18/2021 Signature of Reporting Person Date

Explanation of Responses:

( 1 )25% of the shares of Class A common stock subject to the Stock Option vested on June 3, 2021 and the remaining 75% vest in a series of thirty-six successive equal monthly installments thereafter, subject to the Reporting Person's continuous service with the issuer. ( 2 )The shares of Class A common stock vest in a series of forty-eight successive equal monthly installments beginning on February 16, 2021, subject to the Reporting Person's continuous service with the issuer. ( 3 )The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs vest over a four-year period, with 6.25% of the RSUs vesting on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after June 15, 2021, subject to the Reporting Person's continuous service with the issuer. ( 4 )The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs vest over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of June 15, 2020 and the remaining 75% vest in equal quarterly installments over the following three years, on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. ( 5 )The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs vest over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after June 15, 2021, subject to the Reporting Person's continuous service with the issuer.

Remarks: Exhibit 24 - Power of Attorney

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.